Protagonist Therapeutics Inc sell StockNews.com
Start price
30.09.23
/
50%
€117.00
Target price
30.09.24
-
Performance (%)
-
End price
01.10.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -1.681% | -1.681% | 144.770% |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % |
Comments by StockNews_com for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€41.80
31.05.25
31.05.25
-
31.05.26
31.05.26
93.78%
01.06.26
01.06.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€117.00
18.10.23
18.10.23
-
18.10.24
18.10.24
-
19.10.24
19.10.24